Outcomes associated with vancomycin-resistant enterococci: A meta-analysis

Infection Control and Hospital Epidemiology

Volumn 24, Issue 9, 2003, Pages 690-698

  Salgado, Cassandra D ^a   Farr, Barry M ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; DISEASE SEVERITY; ENTEROCOCCUS; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MEDLINE; MORTALITY; MULTIVARIATE ANALYSIS; STRAIN DIFFERENCE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN SUSCEPTIBLE ENTEROCOCCUS; VIRUS STRAIN;

BACTEREMIA; ENTEROCOCCUS; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MORBIDITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE;

EID: 0141869007     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502271     Document Type: Article

References (45)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
2. Uttley AH, Collins CH, Naidoo J, George R. Vancomycin-resistant enterococci. Lancet 1988;1:57-58.
3. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140-147.
4. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in healthcare facilities in a region. N Engl J Med 2001;344:1427-1433.
5. National Nosocomial Infection Surveillance (NNIS) System. NNIS system report, data from January 1990-1999, issued June 1999. Am J Infect Control 1999;27:520-532.
6. Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001;357:1179.
7. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522-527.
8. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-670.
9. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36:145-158.
10. Song X, Perl T. Vancomycin-resistant enterococcal (VRE) nosocomial bloodstream infections (BSI): the attributable mortality, length of stay, and excess cost. Presented at the 37th Annual Meeting of the Infectious Diseases Society of America; November 18-21, 1999; Philadelphia, PA.
11. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999;20:318-323.
12. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
13. Stroud L, Edwards J, Danzing L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996;17:576-580.
14. Ostrowsky B, Steinberg JT, Farr B, Sohn AH, Sinkowitz-Cochran RL, Jarvis WR. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol 2001;22:116-119.
15. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999;115:1085-1091.
16. Webb M, Riley LW, Roberts RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis 2001;33:445-452.
17. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234-1239.
18. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996;23:760-766.
19. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-259.
20. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000;30:466-472.
21. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-1285.
22. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998;26:1127-1133.
23. Peset V, Tallon P, Sola C, et al. Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 2000;19:742-749.
24. Gleason T, Crabtree T, Pelletier S, et al. Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic sensitive strains. Arch Surg 1999;134:1033-1040.
25. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;56:1458-1462.
26. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002;34:922-929.
27. Vergis E, Hayden M, Chow J, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. Ann Intern Med 2001;135:484-492.
28. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control 1996;24:372-379.
29. Livornese LL Jr, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-116.
30. Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999;88:651-654.
31. Newell KA, Millis JM, Arnow PM, et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998;65:439-442.
32. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-772.
33. D'Agata EM, Li H, Gouldin C, Tang YW. Clinical and molecular characterization of vancomycin-resistant Enterococcus faecium strains during establishment of endemicity. Clin Infect Dis 2001;33:511-516.
34. Still J, Law E, Friedman B, Fuhrman S, Newton T. Vancomycin-resistant organisms on a burn unit. South Med J 2001;94:810-812.
35. Wells C, Juni B, Cameron S, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical or surgical patients. Clin Infect Dis 1995;21:45-50.
36. Gray J, George R. Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 2000;45:11-18.
37. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995;23:170-180.
38. Krcmery V, Bilikova E, Svetlansky I, Kovacicova G. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia? Clin Infect Dis 2001;32:1110-1112.
39. Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998;19:647-652.
40. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-1133.
41. Kapur D, Dorsky D, Feingold JM, et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2000;25:147-152.
42. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR 1993;42:597-598.
43. Mainous MR, Lipsett PA, O'Brien M, Johns Hopkins SICU Study Group. Enterococcal bacteremia in the surgical intensive care unit: does vancomycin resistance affect mortality? Arch Surg 1997;132:76-81.
44. Jernigan J, Hadziyannis E, Schwarzmann S, Nolte F. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in severely neutropenic patients. Presented at the 36th Annual Meeting of the Infectious Diseases Society of America; September 18-20, 1996; New Orleans, LA.
45. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic model: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.